A network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scale

Neurodegenerative diseases are associated with the assembly of specific proteins into oligomers and fibrillar aggregates. At the brain scale, these protein assemblies can diffuse through the brain and seed other regions, creating an autocatalytic protein progression. The growth and transport of thes...

Full description

Bibliographic Details
Main Authors: Brennan, GS, Goriely, A
Format: Journal article
Language:English
Published: Springer 2025
_version_ 1824459069582213120
author Brennan, GS
Goriely, A
author_facet Brennan, GS
Goriely, A
author_sort Brennan, GS
collection OXFORD
description Neurodegenerative diseases are associated with the assembly of specific proteins into oligomers and fibrillar aggregates. At the brain scale, these protein assemblies can diffuse through the brain and seed other regions, creating an autocatalytic protein progression. The growth and transport of these assemblies depend on various mechanisms that can be targeted therapeutically. Here, we use spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain to study the effect of different drugs on whole-brain Alzheimer’s disease progression.
first_indexed 2025-02-19T04:35:55Z
format Journal article
id oxford-uuid:2d2b0bed-1032-40e4-859c-9915a0d19a34
institution University of Oxford
language English
last_indexed 2025-02-19T04:35:55Z
publishDate 2025
publisher Springer
record_format dspace
spelling oxford-uuid:2d2b0bed-1032-40e4-859c-9915a0d19a342025-02-03T09:03:49ZA network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scaleJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2d2b0bed-1032-40e4-859c-9915a0d19a34EnglishSymplectic ElementsSpringer2025Brennan, GSGoriely, ANeurodegenerative diseases are associated with the assembly of specific proteins into oligomers and fibrillar aggregates. At the brain scale, these protein assemblies can diffuse through the brain and seed other regions, creating an autocatalytic protein progression. The growth and transport of these assemblies depend on various mechanisms that can be targeted therapeutically. Here, we use spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain to study the effect of different drugs on whole-brain Alzheimer’s disease progression.
spellingShingle Brennan, GS
Goriely, A
A network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scale
title A network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scale
title_full A network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scale
title_fullStr A network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scale
title_full_unstemmed A network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scale
title_short A network aggregation model for amyloid-β dynamics and treatment of Alzheimer’s diseases at the brain scale
title_sort network aggregation model for amyloid β dynamics and treatment of alzheimer s diseases at the brain scale
work_keys_str_mv AT brennangs anetworkaggregationmodelforamyloidbdynamicsandtreatmentofalzheimersdiseasesatthebrainscale
AT gorielya anetworkaggregationmodelforamyloidbdynamicsandtreatmentofalzheimersdiseasesatthebrainscale
AT brennangs networkaggregationmodelforamyloidbdynamicsandtreatmentofalzheimersdiseasesatthebrainscale
AT gorielya networkaggregationmodelforamyloidbdynamicsandtreatmentofalzheimersdiseasesatthebrainscale